Elizabeth Murphy Lilly - 31 Mar 2025 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role: Director
Signature: /s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Issuer symbol: APOG
Transactions as of: 31 Mar 2025
Net transactions value: +$973
Form type: 4
Filing time: 02 Apr 2025, 11:27:31 UTC
Previous filing: 03 Jan 2025
Next filing: 27 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APOG	Deferred Restricted Stock Units	Award	$973	+21	+0.56%	$46.33	3,779	31 Mar 2025	Common Stock	21		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Settled 1-for-1.
F2	Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.
F3	The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.